Organization | University of Bergen

University of Bergen Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Bergen Norway (1946)

Organization Overview

First Clinical Trial

1995

NCT01422317

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Alternative names

Centre For International Health | Centre for International Health, University of Bergen, 5021 Bergen, Norway | CISMAC, Center forInternational Health, University of Bergen | Department of Internal Medicine, University of Bergen, 5021 Armauer Hanssen Hus, Bergen, NORWAY | Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway | Department of Medicine,Haukeland University Hospital, Bergen, Norway | Department of Medicine, the Division of Cardiology, the Central Hospital in Rogaland, Norway, and the University of Bergen, Norway | Department of Oncology and Medical Physics, Haukeland University Hospital | Department of Oncology, Haukeland University Hospital | Department of Oncology, Haukeland University Hospital, Bergen, Norway | Dep. of Anesthesia and Intensive Care, Haukeland University Hospital, 5021 Bergen , Norway | Dep. of Neurology, Haukeland University Hospital | Dept. Neurology, Haukeland University Hospital, Bergen | Dept. Neurology, Haukeland University Hospital, Bergen, Norway | Dept. Neurology, Haukeland University HospitalBergen, Norway | Dept. of Clinical Science and Lab. of Clinical Biochemistry, Univ. of Bergen and Haukeland University Hospital, Bergen, N5021, Norway | Dept. of Oncology and Medical Physics, Haukeland University Hospital | Dept. of Oncology, Haukeland University Hospital, Bergen, Norway | Grieg Academy, University of Bergen | Haugesund Hospital and University of Bergen | Haukeland UH | Haukeland Univeristy Hospital | Haukeland University | Haukeland University Hospial | Haukeland University Hospital | Haukeland University Hospital, 5021 Bergen, Norway | Haukeland University Hospital, Bergen, Norway | Haukeland University Hospital, Department of Heart Disease | Haukeland University Hospital, Department of Medicine | Haukeland University Hospital, Pediatric department | HAUKELAND UNIVERSITY HOSPITAL, PEDIATRIC DEPARTMENT | Haukeland University Hospital, thoracic department | Haukeland Univ Hospital | Helse Møre og Romsdal Hospital trust | Innlandet Hospital Trust / University of Bergen | Laboratory of Clinical Biochemistry, Haukeland University Hospital, N-5021 Bergen, Norway | Locus for Cardiac Research, University of Bergen, Norway | Locus for Homocysteine and Related Vitamins, University of Bergen, Norway | Medical Director, Kirurgisk Serviceklinikk, Haukeland Universitetssykehus | Pain Clinic, Haukeland University Hospital, 5021 Bergen, Norway | Rebecca Cox | Satya Pal Sharma | The Gade Institute, Haukeland University Hospital, Bergen | The University of Bergen | Tiina Maarit Andersen | UiB | Unifob health, University of Bergen | University of Bergen | University of Bergen. Helse-Bergen HF | University of Bergen. Helse-Bergen HF. | University of Bergen, Norway | Universtity of Bergen

University of Bergen Report issue

Drugs in Phase 4 Trials (36)

Drugs in Phase 3 Trials (52)

Drugs in Phase 2 Trials (58)

Drugs in Phase 1 Trials (12)

Drugs in Other Trials (34)

Experimental Indications (Clinical Trials, Phases 1-4)

Overview